|
Our drug attorneys are currently reviewing possible gadolinium dye lawsuits.
Were you harmed after receiving a Gadolinium contrast agent during an MRI? Get a free lawsuit review when you complete the form below. We will determine if you have a possible Gadolinium MRI contrast dye case.
The first case of NSF was identified in 1997. It has been reported only in patients who have severe kidney disease.
NSF causes fibrosis of the skin and connective tissues throughout the body.
Patients develop skin thickening that may prevent bending and extending joints, resulting in decreased mobility of joints.
NSF usually starts in the lower extremities.
Fibrosis can also develop in the diaphragm, muscles in the thigh and lower abdomen, and lung vessels. Over time, NSF becomes worse and can cause death.
According to the Food and Drug Administration, NSF has been reported following administration of all five FDA approved gadolinium-based contrast agents (Magnevist, MultiHance, Omniscan, OptiMARK, and ProHance).
A lawyer well-versed in defective drug cases can help you gain the lawsuit compensation you deserve from harmful side effects resulting from Gadolinium.
A representative will contact you shortly to let you know if we can help with a possible lawsuit.
see also:
Possible Cases
Discuss Your MRI Dye Case With Gadolinium Lawyers. Free Lawsuit ReviewDid gadolinium dye cause serious health concerns? Gadolinium Lawyers.
Research Center
Health Risk to use of Gadolinium MRI Contrast Dye. Free Lawsuit InfoGadolinium MRI contrast dye may lead to Nephrogenic Systemic Fibrosis
Gadolinium
The gadolinium contrast dye used in MRIs may cause nephrogenic systemic fibrosis (NSF)Did you develop Nephrogenic Systemic Fibrosis (NSF) from Gadolinium dye? Weitz & Luxenberg can help.
